Advertisement
Screener

Vir Biotechnology, Inc. (VIR) Pre-Tax Margin

Vir Biotechnology, Inc. (VIR) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 33.59%.
  • 2026-03-31: Pre-Tax Margin 432844.83%.
  • 2025-12-31: Pre-Tax Margin -67.21%.
  • 2025-09-30: Pre-Tax Margin -67905.42%.

Complete source-backed pre-tax margin history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3033.59%
2026-03-31432844.83%
2025-12-31-67.21%
2025-09-30-67905.42%
2025-06-30-9125.86%
2025-03-31-3989.08%
2024-12-31-845.93%
2024-09-30-8972.27%
2024-06-30-4549.27%
2024-03-31-115.30%
2023-12-31-719.35%
2023-09-30-6313.98%
2023-06-30-5204.71%
2023-03-31-227.44%
2022-12-31-306.90%
2022-09-3058.13%
2022-06-30575.26%
2022-03-3174.80%
2021-12-3167.17%
2021-09-30106.90%
2021-06-3034.94%
2021-03-31-8538.21%
2020-12-31-6094.52%
2020-09-30-4387.29%
2020-06-30-46.46%
2020-03-31-1350.54%
2019-12-31-6492.04%
2019-09-30-3444.55%
2019-06-30-1656.52%
2019-03-31-783.12%
2018-12-31-843.67%
2018-09-30-1159.65%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-638.56%
2024-12-31-704.95%
2023-12-31-728.93%
2022-12-3146.68%
2021-12-3150.19%
2020-12-31-391.02%
2019-12-31-2157.08%
2018-12-31-1090.78%
2017-12-31-2982.87%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40